Compare CNQ & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNQ | ABT |
|---|---|---|
| Founded | 1973 | 1888 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.8B | 152.9B |
| IPO Year | 2001 | 2006 |
| Metric | CNQ | ABT |
|---|---|---|
| Price | $49.81 | $116.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 20 |
| Target Price | $57.00 | ★ $130.90 |
| AVG Volume (30 Days) | 5.5M | ★ 5.8M |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.68% | 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $5.85 | $10.75 |
| Revenue Next Year | N/A | $8.10 |
| P/E Ratio | ★ $18.33 | $191.25 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $29.68 | $81.97 |
| 52 Week High | $51.48 | $137.49 |
| Indicator | CNQ | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 65.11 | 75.26 |
| Support Level | $44.42 | $111.18 |
| Resistance Level | $51.16 | $116.82 |
| Average True Range (ATR) | 0.86 | 2.06 |
| MACD | 0.23 | 0.22 |
| Stochastic Oscillator | 80.61 | 89.30 |
Canadian Natural Resources is the largest producer of oil and the second-largest producer of natural gas in Canada. It is principally involved in extracting heavy oils, natural gas, and bitumen through its drilling and mining operations. Bitumen from mining operations is upgraded into synthetic crude oil. Commodities produced are primarily exported to the US via pipeline. The company also has smaller offshore production operations in the North Sea and Africa.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.